Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis

The recruitment status of this study is unknown because the information has not been verified recently.

Verified March 2006 by Hadassah Medical Organization.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Hadassah Medical Organization

ClinicalTrials.gov Identifier:

NCT00299637

First received: March 5, 2006

Last updated: November 29, 2006

Last verified: March 2006

History of Changes

Purpose

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

Condition	Phase
Chorioamnionitis	Phase 0


Study Type:	Observational
Study Design:	Observational Model: Case Control Observational Model: Natural History Time Perspective: Cross-Sectional Time Perspective: Prospective
Official Title:	Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis During Labor Comparing to Fetuses to Healthy Mothers.

Resource links provided by NLM:

Genetic and Rare Diseases Information Center resources: Placenta Disorder

U.S. FDA Resources

Further study details as provided by Hadassah Medical Organization:


Estimated Enrollment:	34
Study Start Date:	October 2006
Estimated Study Completion Date:	December 2007

Detailed Description:

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

MCA flow parameters will be evaluated during labor of women with and wthout chorioamnionitis

Eligibility


Ages Eligible for Study:	20 Years to 45 Years (Adult)
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

women giving birth week 37-42
healthy
one fetus

Exclusion Criteria:

more than one fetus
IUGR
illness or damage to fetus

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00299637

Contacts


Contact: david mankuta, MD		mankuta@yahoo.com

Locations


Israel
Haddasah Medical Organization	Recruiting
Jerusalem, Israel, 12000
Contact: David Mankuta
Principal Investigator: David Mankuta

Sponsors and Collaborators

Hadassah Medical Organization

Investigators


Study Chair:	David Mankuta, MD	Hadassah Medical Organization

More Information


ClinicalTrials.gov Identifier:	NCT00299637 History of Changes
Other Study ID Numbers:	MCA chorioamnionitis HMO-CTIL
Study First Received:	March 5, 2006
Last Updated:	November 29, 2006
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:


Chorioamnionitis Fetal Diseases Pregnancy Complications	Fetal Membranes, Premature Rupture Obstetric Labor Complications Placenta Diseases

ClinicalTrials.gov processed this record on September 30, 2016

To Top